To investigate whether GDPD3 expression was altered in human CML patients, we retrieved data on levels of GDPD3 mRNA in cells of imatinib-treated CML patients listed in a public database GEO (GEO: GSE12211)30. This evidence concerns the gene GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive.